Jeff Schaffnit

Jeff Schaffnit is a motivated and proven biotech executive currently serving as the General Manager and Head of Rare Blood Disorders at Sanofi. With extensive experience in developing and implementing innovative commercial strategies, they have held leadership roles at companies such as Baxalta and Shire, driving significant growth in rare disease markets. Jeff has successfully led high-performing teams across various sectors, achieving substantial revenue increases and successful product launches. They hold an MBA from the Kellogg School of Management and a Bachelor of Science in Chemical Engineering from the University of Illinois at Urbana-Champaign.